Skip to main content
. 2019 May 30;18(2):1218–1224. doi: 10.3892/ol.2019.10416

Figure 2.

Figure 2.

Upregulation of lncRNA-CCHE1 distinguishes patients with metastatic pancreatic adenocarcinoma from patients with non-metastatic pancreatic adenocarcinoma and healthy controls. Receiver operating characteristic curve analysis revealed that upregulation of lncRNA-CCHE1 distinguished patients with metastatic pancreatic adenocarcinoma from (A) patients with non-metastatic pancreatic adenocarcinoma and (B) healthy controls. CCHE1, cervical carcinoma high-expressed lncRNA 1; lncRNA, long non-coding RNA.